Adenocarcinoma of the lung other diagnostic studies

Revision as of 15:30, 5 January 2016 by Shanshan Cen (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Adenocarcinoma of the Lung Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adenocarcinoma of the Lung from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Stage I
Stage II
Stage III
Stage IV
Metastatic Cancer

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adenocarcinoma of the lung other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adenocarcinoma of the lung other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adenocarcinoma of the lung other diagnostic studies

CDC on Adenocarcinoma of the lung other diagnostic studies

Adenocarcinoma of the lung other diagnostic studies in the news

Blogs on Adenocarcinoma of the lung other diagnostic studies

Directions to Hospitals Treating Adenocarcinoma of the lung

Risk calculators and risk factors for Adenocarcinoma of the lung other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Other diagnostic studies for adenocarcinoma of the lung include molecular test and endoscopic procedures.[1]

Other Diagnostic Studies

Molecular test[1]

  • Molecular tissue tests look for certain changes in the genes of non–small cell lung cancer cells. These genetic mutations may change how much or the type of protein the cancer cells produce. These changes may affect the type of treatment given because some chemotherapy drugs may be more effective against cancer cells with these changes. Molecular tissue tests may also help predict prognosis.
  • Molecular tissue tests for non-small cell lung cancer look for the genes responsible for:
  • Specific mutations in these genes are associated with a better response to some drugs.

Endoscopic procedures[1]

  • A bronchoscopy may be done to look for a tumour inside the bronchi.
  • During a bronchoscopy, the doctor may remove a sample of tissue or fluid to be examined under a microscope to diagnose non–small lung cancer.
  • A mediastinoscopy may be done to look at the mediastinum
  • The space in the chest between the lungs, breastbone and spine that contains the heart, great blood vessels, thymus, trachea (windpipe), esophagus and lymph nodes. and get samples of tissues in the area.
  • A mediastinotomy is similar to mediastinoscopy. Instead of inserting an endoscope through a cut in the neck, the doctor makes a slightly larger incision between the ribs. This allows the doctor to examine lymph nodes that cannot be reached by a mediastinoscopy.
  • A thoracoscopy may be done to look at and sample tissue from the chest wall, mediastinum, outer lining of the lungs (pleura) and lymph nodes in the chest.
  • Thoracoscopy is not often done to diagnose lung cancer. It may be used if other tests, such as bronchoscopy, cannot get enough tissue to make a diagnosis.

References


Linked-in.jpg